Anti-LYVE1/ CRSBP-1/ HAR monoclonal antibody

Anti-LYVE1/ CRSBP-1/ HAR antibody for FACS & in-vivo assay

Target products collectionGo to LYVE1/LYVE1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T54055-Ab-1/ GM-Tg-hg-T54055-Ab-2Anti-Human LYVE1 monoclonal antibodyHuman
GM-Tg-rg-T54055-Ab-1/ GM-Tg-rg-T54055-Ab-2Anti-Rat LYVE1 monoclonal antibodyRat
GM-Tg-mg-T54055-Ab-1/ GM-Tg-mg-T54055-Ab-2Anti-Mouse LYVE1 monoclonal antibodyMouse
GM-Tg-cynog-T54055-Ab-1/ GM-Tg-cynog-T54055-Ab-2Anti-Cynomolgus/ Rhesus macaque LYVE1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T54055-Ab-1/ GM-Tg-felg-T54055-Ab-2Anti-Feline LYVE1 monoclonal antibodyFeline
GM-Tg-cang-T54055-Ab-1/ GM-Tg-cang-T54055-Ab-2Anti-Canine LYVE1 monoclonal antibodyCanine
GM-Tg-bovg-T54055-Ab-1/ GM-Tg-bovg-T54055-Ab-2Anti-Bovine LYVE1 monoclonal antibodyBovine
GM-Tg-equg-T54055-Ab-1/ GM-Tg-equg-T54055-Ab-2Anti-Equine LYVE1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T54055-Ab-1/ GM-Tg-hg-T54055-Ab-2; GM-Tg-rg-T54055-Ab-1/ GM-Tg-rg-T54055-Ab-2;
GM-Tg-mg-T54055-Ab-1/ GM-Tg-mg-T54055-Ab-2; GM-Tg-cynog-T54055-Ab-1/ GM-Tg-cynog-T54055-Ab-2;
GM-Tg-felg-T54055-Ab-1/ GM-Tg-felg-T54055-Ab-2; GM-Tg-cang-T54055-Ab-1/ GM-Tg-cang-T54055-Ab-2;
GM-Tg-bovg-T54055-Ab-1/ GM-Tg-bovg-T54055-Ab-2; GM-Tg-equg-T54055-Ab-1/ GM-Tg-equg-T54055-Ab-2
Products NameAnti-LYVE1 monoclonal antibody
Formatmab
Target NameLYVE1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LYVE1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LYVE1/ CRSBP-1/ HAR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004977human LYVE1 Lentivirus particle
    ORF Viral VectorpGMLP004977human LYVE1 Lentivirus plasmid
    ORF Viral VectorpGMLPm000409mouse Lyve1 Lentivirus plasmid
    ORF Viral VectorvGMLPm000409mouse Lyve1 Lentivirus particle


    Target information

    Target IDGM-T54055
    Target NameLYVE1
    Gene ID10894,114332,293186,702941,100855439,101087867,404179,100055858
    Gene Symbol and Synonyms1200012G08Rik,CRSBP-1,HAR,LYVE-1,LYVE1,XLKD1
    Uniprot AccessionQ9Y5Y7,Q6UC88
    Uniprot Entry NameLYVE1_HUMAN,LYVE1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000133800
    Target ClassificationTumor-associated antigen (TAA)

    The target: LYVE1, gene name: LYVE1, also named as CRSBP-1, HAR, LYVE-1, XLKD1. This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.